Are These 3 Jim Cramer’s Stock Picks a Buy? Here’s What Analysts Think

In This Article:

The one good thing about a market downturn? You get lots of opportunities to load up on shares at a discount entry point. And who doesn’t like a discount?

With the way the markets have performed so far this year, there are stocks in every segment which could potentially offer plenty of rewards.

CNBC’s Jim Cramer thinks there are several names in the retail sector which look particularly enticing right now, ones for which the term “beaten-down” readily applies. Some rallied nicely toward the end of last week, but following the severe market-wide pullback, Cramer notes that it will take “many more days” before multiple names approach “being expensive again.”

Taking a look at Cramer’s choices, we ran through the TipRanks database three stocks the Mad Money host thinks will make good additions to investors’ portfolios. This way we can gauge whether Wall Street’s cadre of experts agree with his selections. Let’s take a look at the results.

Bath & Body Works (BBWI)

Lots of stocks might be on sale right now but the same cannot be said of household goods. Prices are on the up, and macroeconomic worries around consumer spending amid rising inflation have investors feeling shaky in 2022. Shares of Bath & Body Works have suffered from this development and are down by 41% from the peak notched in November.

The company is the U.S.’s biggest specialty home fragrance & fragrant body care business, boasting more than 2,000 U.S. and international stores, a meaningful online presence and serving north of 50 million consumers. Last August, the company rebranded from L Brands to its current moniker and spun off its Victoria’s Secret business. Now, its three main revenue generating segments - home fragrance, body care & fragrances and soaps & sanitizers – helped the company deliver revenue of $7.882 billion in 2021 (for the period ending on Jan 31).

At the same time, the company raked in record sales in 4Q21, dialing in a set of results which beat Street expectations. Revenue increased by 11.4% year-over-year to reach $3.03 billion, just beating the Street’s $2.96 billion estimate. Non-GAAP EPS of $2.30 also beat Wall Street’s forecast - by $0.03.

However, the company’s forecast called for modest earnings declines for Q1 and for the full-year 2022, developments investors did not like, while CEO Andrew Meslow’s departure on health reasons further clouded the outlook.

That said, BMO’s Simeon Siegel agrees with Cramer’s assessment that the stock is ripe for the picking at present. The analyst writes: “We believe the challenging environment, a broad lack of investor appetite and expectations of this conservative guide have created extremely compelling long-term entry points and we suggest buying the recent weakness as we see upside to the reset numbers and long-term multiple re-rating.”